Form 4 for PCRX Pacira BioSciences, Inc.
Accepted 2021-07-30 00:00:00 ET · period of report 2021-07-28 · accession 0001209191-21-048784 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-07-30 | 2021-07-28+ | PCRX | Riker Lauren Bullaro | VP, Fin | S - Sale+OE | $60.85 | -2,500 | 13.2K | -16% | -$152.1K |
| DM | 2021-07-30 | 2021-07-28+ | PCRX | Riker Lauren Bullaro | VP, Fin | M - OptEx | $10.81 | +2,500 | 15.6K | +19% | +$27.0K |
| DM | 2021-07-30 | 2021-07-28+ | PCRX | Riker Lauren Bullaro | VP, Fin | M - OptEx | $0.00 | -2,500 | 11.8K | -17% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-29 | S | D | 90 | $60.81 | 13,152 | D | — | — | |
| 2 | Common | Common Stock | 2021-07-29 | M | A | 90 | $10.81 | 13,242 | D | — | — | |
| 3 | Common | Common Stock | 2021-07-28 | S | D | 2,410 | $60.85 | 13,152 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.81 to $60.858, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 4 | Common | Common Stock | 2021-07-28 | M | A | 2,410 | $10.81 | 15,562 | D | — | — | (F2) Includes 421 shares of common stock acquired under the issuer's employee stock purchase plan in June 2021. |
| 5 | Derivative | Stock Option (Right to Buy) | 2021-07-28 | M | D | 2,410 | $0.00 | 11,890 | D | $10.81 · — to 2022-06-05 | 2,410 Common Stock | (F4) The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and vested as to the remaining shares in successive equal monthly installments for the subsequent 36 months. |
| 6 | Derivative | Stock Option (Right to Buy) | 2021-07-29 | M | D | 90 | $0.00 | 11,800 | D | $10.81 · — to 2022-06-05 | 90 Common Stock | (F4) The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and vested as to the remaining shares in successive equal monthly installments for the subsequent 36 months. |